Top Traded by Value Today 09-Nov-2026: Banks and Pharma Lead
Key highlights
- State Bank of India gained 2.43% to Rs. 1,041.45 as the Nifty PSU Bank index rose 3.25%.
- Divis Laboratories Ltd rose 4.42% after September-quarter net profit increased 64% year-on-year.
- Aarti Drugs Ltd was the biggest gainer in the supplied list, up 11.13% on 2.44 crore shares.
- The Nifty 50 closed 0.23% higher at 25,044.65 and the Sensex gained 0.13% to 81,106.65.
powered by IRIS

Top Traded by Value Today on 09-Nov-2026 were led by State Bank of India, up 2.43%, and pharma names including Divis Laboratories, up 4.42%, as the Nifty 50 closed at 25,044.65 (+0.23%) and Sensex at 81,106.65 (+0.13%). PSU banks and pharma drove gains, while foreign investors bought more than $4.1 billion of Indian equities so far in November.
Which large-cap stocks were top traded by value today?
Large-cap value turnover concentrated in financials, with HDFC Bank Ltd, ICICI Bank Ltd and State Bank of India advancing alongside a 3.25% rise in the Nifty PSU Bank index.
HDFC Bank Ltd (+1.52%)
HDFC Bank Ltd gained as banking shares supported the benchmark, with the Nifty Financial Services 25/50 index rising 0.81% and the Nifty Private Bank index adding 0.53%. Its 6.88 crore shares traded made it the highest-volume stock in this large-cap value list, supporting the session's positive price momentum.
ICICI Bank Ltd (+1.21%)
ICICI Bank Ltd climbed after moving above its second resistance level and registering a fresh 52-week high during the session. The close at Rs. 1,585 was just below its Rs. 1,589.95 52-week high, while 2.99 crore shares changed hands as financial stocks outperformed.
Divis Laboratories Ltd (+4.42%)
Divis Laboratories Ltd surged after reporting a 64% year-on-year increase in September-quarter net profit, with revenue and EBITDA rising 35% and 76%, respectively. JPMorgan retained an Overweight rating and raised its target price to Rs. 12,500, while Goldman Sachs retained a Buy rating after the results exceeded estimates; the Nifty Pharma index rose 1.51%.
Reliance Industries Ltd (+0.07%)
Reliance Industries Ltd ended marginally higher after S&P Global Ratings affirmed its A- long-term issuer rating and stable outlook, citing resilient earnings, cash generation and improved funding flexibility after the Jio Platforms listing. The limited 0.07% move despite 2.09 crore shares traded reflected a range-bound market and pressure on oil and gas shares, whose index rose only 0.16%.
State Bank of India (+2.43%)
State Bank of India rallied as investors assessed its Q2FY27 analyst-meet disclosures following strong September-quarter earnings and improving margins. Standalone net profit rose more than 14% year-on-year to Rs. 23,038 crore and net interest income grew nearly 15% to Rs. 49,143 crore, helping SBI lead a 3.25% rise in the Nifty PSU Bank index.
Which mid-cap stocks were top traded by value today?
Mid-cap turnover was led by pharma stocks, which extended their sector rally after recent quarterly results, while Kalyan Jewellers India Ltd drew heavy activity in consumer durables.
Sai Life Sciences Ltd (+5.21%)
Sai Life Sciences Ltd rose with the pharma-led rotation that lifted the Nifty Pharma index 1.51% and the Nifty Healthcare index 1.11%. The stock traded 1.10 crore shares and closed only Rs. 61.80 below its Rs. 1,897.55 52-week high, indicating sustained technical momentum within the sector.
Kalyan Jewellers India Ltd (+3.12%)
Kalyan Jewellers India Ltd gained 3.12% amid strong activity of 1.50 crore shares, placing it among the most actively traded mid-caps by value. The consumer durables index rose 0.77%, providing sector support, while the close at Rs. 611 remained below its Rs. 649 52-week high.
Gland Pharma Ltd (+5.60%)
Gland Pharma Ltd rallied as pharma stocks responded to recent quarterly earnings and the Nifty Pharma index climbed 1.51%. The stock was identified as a leading pharma index gainer during the session, and its 25.55 lakh-share volume accompanied a close near its Rs. 3,372 52-week high.
Multi Commodity Exchange of India Ltd (-0.18%)
Multi Commodity Exchange of India Ltd edged lower after recent record-high activity, with the stock having been among NSE 500 names to hit a lifetime high in the Muhurat session. The Rs. 6.25 decline came on 23.72 lakh shares, signalling modest profit booking rather than a broad financial-sector reversal.
Glenmark Pharmaceuticals Ltd (+3.27%)
Glenmark Pharmaceuticals Ltd gained as the pharma sector outperformed, with the Nifty Pharma index rising 1.51% and healthcare adding 1.11%. Its 18.94 lakh-share turnover and close at Rs. 2,679.90, close to the Rs. 2,713.75 52-week high, reinforced the sector-led move.
Got a follow-up? Ask IRIS
Which small-cap stocks were top traded by value today?
Small-cap value trading featured sharp momentum moves in Data Patterns (India) Ltd, KPI Green Energy Ltd and Aarti Drugs Ltd, although Finolex Cables Ltd saw selling pressure on high volume.
Data Patterns (India) Ltd (+8.65%)
Data Patterns (India) Ltd jumped 8.65% on turnover of 38.25 lakh shares, a strong price-and-volume move among the day's active small caps. No company-specific announcement was provided in the available news context, so the session indicates technical momentum rather than a disclosed fundamental catalyst.
KPI Green Energy Ltd (+8.54%)
KPI Green Energy Ltd rose 8.54% with 4.34 crore shares traded, the largest volume among the small-cap value names listed. No specific company announcement was supplied, making the high-volume advance the available indicator of momentum in the counter.
Aarti Drugs Ltd (+11.13%)
Aarti Drugs Ltd was the strongest gainer in this small-cap value list, rising 11.13% on 2.44 crore shares. The stock closed at Rs. 500.30, within about 6% of its Rs. 533.60 52-week high, pointing to a technical recovery alongside the broader pharma-sector advance.
Tonbo Imaging India Ltd (+1.79%)
Tonbo Imaging India Ltd added 1.79% as 65.57 lakh shares traded, placing it among the highest-turnover small-cap names. No specific corporate catalyst was included in the supplied context, and the modest gain indicates stock-specific trading activity rather than a confirmed event-driven move.
Finolex Cables Ltd (-5.96%)
Finolex Cables Ltd fell 5.96% on heavy turnover of 76.38 lakh shares, the highest volume in this small-cap group. No company-specific negative disclosure was provided, while the session's pressure on select cyclical and industrial shares left the stock materially below its Rs. 1,498.35 52-week high.
How did the Indian stock market perform on 09-Nov-2026?
Indian equities finished modestly higher after a volatile, range-bound session, with the Sensex gaining 107.25 points to 81,106.65 and the Nifty 50 rising 58.25 points to 25,044.65. The Nifty opened at 25,076.40, touched 25,084.05, and fell as low as 24,838.75 before recovering into the close.
PSU banks led sectoral gains, with the Nifty PSU Bank index up 3.25%, followed by Nifty Pharma at 1.51%, Healthcare at 1.11%, Financial Services 25/50 at 0.81% and Private Bank at 0.53%. Nifty IT declined 1.56%, Nifty Metal fell 0.49% and FMCG lost 0.36%, as profit booking followed the previous week's rally.
Foreign investors had bought more than $4.1 billion of Indian equities so far in November, supporting large-cap financials. Lower crude also aided the domestic macro backdrop, with Brent at $97.42 per barrel and WTI at $90.39 per barrel, while investors await Indian and US inflation data for interest-rate signals.
Where can readers find more top traded by value stocks?
Readers can explore the complete list of market movers here:
https://www.multibagg.ai/market-movers/top-gainers
Conclusion
The day's value turnover showed a selective market rather than a broad risk-on move: PSU banks were supported by strong reported earnings and margin trends, while pharma stocks gained on quarterly numbers that exceeded expectations. The benchmark advance remained contained because IT, metals and FMCG weakened, even as the Nifty Smallcap 100 ended marginally higher.
Investors will next watch India and US inflation data, crude prices and global risk sentiment for interest-rate cues. For State Bank of India, the post-results analyst-meet disclosures and credit-growth trajectory remain relevant; for Divis Laboratories, the conversion of validation batches into commercial supplies across dedicated programmes is the key disclosed operational milestone to monitor.


